Receptors of Steroid Hormones, Prolactin, and Somatotropin (Growth Hormone) in Human Pituitary Adenomas

  • O. Hey
  • K. Pollow
  • M. Schommer
  • G. Hoffmann
  • J. Happ
Conference paper
Part of the Advances in Neurosurgery book series (NEURO, volume 13)


It is generally accepted that hormone receptors are protein molecules which are not ubiquitous but are found in or attached to a target cell. In the interaction of a hormone with its receptor on target cell membranes, the initial step is the specific binding of the hormone with the receptor. The resulting phenomenon, which has been dealt with in a number of excellent articles (4, 6, 8–10), is termed the hormone-receptor complex.


Growth Hormone Pituitary Tumor Ergot Alkaloid Prolactin Secretion Prolactin Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kebian, J.W., Calne, D.B.: Multiple receptors for dopamine. Nature 277, 93–96 (1979)CrossRefGoogle Scholar
  2. 2.
    Lüdecke, D.K., Trams, G., Saeger, W.: Sex hormone receptors in human pituitary adenomas. Acta endocrinologica 23, 104 (1983)Google Scholar
  3. 3.
    Mashiter, K., Adams, E., Beard, M., Holley, A.: Bromocriptine inhibits prolactin and growth hormone release by human pituitary tumors in culture. Lancet II, 197 (1977)Google Scholar
  4. 4.
    O’Malley, B.W., Schrader, W.T.: The receptors of steroid hormones. Scient. Am. 234 32 (1976)Google Scholar
  5. 5.
    Pichon, M.F., Bression, D., Peillon, F., Milgrom, E.: J. Clin. Endocrinol. Metab. 51, 897 (1980)CrossRefGoogle Scholar
  6. 6.
    Pollow, K.: Die Bedeutung von Hormonrezeptoren für die Behandlung maligner Erkrankungen. Therapiewoche 33, 6809–6825 (1983)Google Scholar
  7. 7.
    Rosenfeld, M.R., Makman, H.H., Ahn, H.W., Thal, L.J., Mishra, R.K., Katzmann, R.: Selective influence of ergot alkaloids on cortical and striataldopaminergic and serotoninergic receptors. In: Goldstein, M., Calne, D.B., Liebermann, A., Thorner, M.O. (eds.) Ergot compounds and brain function. Neuroendocrine and neuropsychiatric aspects, pp. 83–93. Raven Press, New York 1980Google Scholar
  8. 8.
    Roth, J.: Metabolism 22, 1059 (1973)PubMedCrossRefGoogle Scholar
  9. 9.
    Shin, R.P.C., Friesen, H.F.: Prolactin receptors. Meth. Mol. Biol. 9, 565–598 (1976)Google Scholar
  10. 10.
    Sutherland, E.W.: Zur Wirkungsweise der Hormone. Angew. Chem. 84, 11, 117 (1972)Google Scholar
  11. 11.
    Yanai, R., Nagasawa, H.: Effect of bromocriptine on pituitary synthesis and release of prolactin and growth hormone in rats. Horm. Res. 5, 1–5 (1974)PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • O. Hey
    • 1
  • K. Pollow
    • 2
  • M. Schommer
    • 2
  • G. Hoffmann
    • 2
  • J. Happ
    • 3
  1. 1.NeurochirurgischeUniversitätsklinikMainzGermany
  2. 2.Abteilung für Experimentelle EndokrinologieUniversitäts-FrauenklinikMainzGermany
  3. 3.Abteilung für Nuklearmedizin der UniversitätFrankfurtGermany

Personalised recommendations